Q3 2024 · CIK 1103804 Snapshot · — Export CSV
Manager file · vg · VIKING GLOBAL INVESTORS LP

Viking Global Investors

EDGAR CIK 1103804 ↗ · Waiting · typical filing lag 45 days

Export CSV
Reported portfolio value
$27.44B
first quarter on file
Positions
83
no prior quarter
Top 10 concentration
38.6%
largest position 5.6%
Position churn · Q3 2024
— added · — trimmed
new positions — · exits — of book
Holdings · Q3 2024 · 83
Security Weight Δ wt Price* Shares Δ shares Value Action
1 USB US BANCORP DEL 5.60% — $46 33.62M new $1.54B New
2 ADBE ADOBE INC 4.95% — $518 2.62M new $1.36B New
3 AAPL APPLE INC 4.13% — $233 4.86M new $1.13B New
4 PM PHILIP MORRIS INTL INC 4.01% — $121 9.05M new $1.10B New
5 V VISA INC 3.51% — $275 3.51M new $964M New
6 — SPOTIFY TECHNOLOGY S A 3.46% — $369 2.58M new $950M New
7 FTV FORTIVE CORP 3.39% — $79 11.80M new $931M New
8 PGR PROGRESSIVE CORP 3.22% — $254 3.49M new $885M New
9 MSFT MICROSOFT CORP 3.21% — $430 2.04M new $880M New
10 APG API GROUP CORP 3.09% — $33 25.71M new $849M New
11 WDAY WORKDAY INC 2.91% — $244 3.27M new $799M New
12 BAC BANK AMERICA CORP 2.89% — $40 19.96M new $792M New
13 JPM JPMORGAN CHASE & CO. 2.84% — $211 3.70M new $779M New
14 AMZN AMAZON COM INC 2.75% — $186 4.05M new $755M New
15 BMRN BIOMARIN PHARMACEUTICAL INC 2.50% — $70 9.75M new $686M New
16 BBIO BRIDGEBIO PHARMA INC 2.33% — $25 25.12M new $640M New
17 — ROIVANT SCIENCES LTD 2.28% — $12 54.10M new $624M New
18 — FLUTTER ENTMT PLC 2.20% — $237 2.55M new $604M New
19 DASH DOORDASH INC 1.87% — $143 3.60M new $514M New
20 SHW SHERWIN WILLIAMS CO 1.81% — $382 1.30M new $497M New
21 TEAM ATLASSIAN CORPORATION 1.72% — $159 2.97M new $472M New
22 LVS LAS VEGAS SANDS CORP 1.59% — $50 8.67M new $436M New
23 ALL ALLSTATE CORP 1.41% — $190 2.04M new $387M New
24 MET METLIFE INC 1.35% — $82 4.49M new $370M New
25 CPT CAMDEN PPTY TR 1.33% — $124 2.96M new $366M New
26 — ROYALTY PHARMA PLC 1.25% — $28 12.09M new $342M New
27 MCD MCDONALDS CORP 1.24% — $305 1.12M new $341M New
28 CSX CSX CORP 1.18% — $35 9.35M new $323M New
29 HCA HCA HEALTHCARE INC 1.03% — $406 698K new $284M New
30 VRT VERTIV HOLDINGS CO 1.02% — $99 2.81M new $280M New
31 NVDA NVIDIA CORPORATION 1.00% — $121 2.27M new $275M New
32 GEV GE VERNOVA INC 0.94% — $255 1.01M new $258M New
33 TRU TRANSUNION 0.92% — $105 2.40M new $251M New
34 TMUS T-MOBILE US INC 0.87% — $206 1.15M new $237M New
35 KKR KKR & CO INC 0.86% — $131 1.81M new $236M New
36 ACHC ACADIA HEALTHCARE COMPANY IN 0.86% — $63 3.70M new $235M New
37 VST VISTRA CORP 0.79% — $119 1.84M new $218M New
38 GOOGL ALPHABET INC 0.77% — $166 1.28M new $212M New
39 ADSK AUTODESK INC 0.77% — $275 762K new $210M New
40 CBRE CBRE GROUP INC 0.71% — $124 1.57M new $196M New
41 — AON PLC 0.71% — $346 563K new $195M New
42 INTU INTUIT 0.66% — $621 290K new $180M New
43 SNPS SYNOPSYS INC 0.65% — $506 352K new $178M New
44 — CARNIVAL CORP 0.64% — $18 9.56M new $177M New
45 SBUX STARBUCKS CORP 0.59% — $97 1.67M new $162M New
46 FCX FREEPORT-MCMORAN INC 0.57% — $50 3.14M new $157M New
47 ADPT ADAPTIVE BIOTECHNOLOGIES COR 0.56% — $5 29.99M new $154M New
48 SCHW SCHWAB CHARLES CORP 0.55% — $65 2.34M new $152M New
49 CRM SALESFORCE INC 0.54% — $274 544K new $149M New
50 NFLX NETFLIX INC 0.53% — $709 205K new $145M New
51 ZS ZSCALER INC 0.53% — $171 848K new $145M New
52 ITGR INTEGER HLDGS CORP 0.53% — $130 1.11M new $144M New
53 TEVAN TEVA PHARMACEUTICAL INDS LTD 0.50% — $18 7.57M new $136M New
54 LLY ELI LILLY & CO 0.49% — $886 152K new $135M New
55 — NEWAMSTERDAM PHARMA COMPANY 0.49% — $17 8.02M new $133M New
56 OSCR OSCAR HEALTH INC 0.48% — $21 6.17M new $131M New
57 CMCSA COMCAST CORP NEW 0.47% — $42 3.09M new $129M New
58 EQH EQUITABLE HLDGS INC 0.47% — $42 3.05M new $128M New
59 MMM 3M CO 0.42% — $137 841K new $115M New
60 AMP AMERIPRISE FINL INC 0.42% — $470 243K new $114M New
61 TSLA TESLA INC 0.42% — $262 436K new $114M New
62 LAB STANDARD BIOTOOLS INC 0.41% — $2 58.65M new $113M New
63 RCI ROGERS COMMUNICATIONS INC 0.40% — $40 2.70M new $109M New
64 RRX REGAL REXNORD CORPORATION 0.38% — $166 630K new $105M New
65 CSGP COSTAR GROUP INC 0.35% — $75 1.26M new $95.14M New
66 BSX BOSTON SCIENTIFIC CORP 0.30% — $84 967K new $81.05M New
67 — PHARVARIS N V 0.25% — $19 3.65M new $67.66M New
68 IMVT IMMUNOVANT INC 0.24% — $29 2.32M new $66.17M New
69 LBPH LONGBOARD PHARMACEUTICALS IN 0.24% — $33 1.97M new $65.63M New
70 LI LI AUTO INC 0.19% — $26 2.08M new $53.23M New
71 REGN REGENERON PHARMACEUTICALS 0.19% — $1.05K 50K new $52.43M New
72 ZLAB ZAI LAB LTD 0.17% — $24 1.95M new $47.07M New
73 CVNA CARVANA CO 0.17% — $174 269K new $46.85M New
74 VKTX VIKING THERAPEUTICS INC 0.17% — $63 722K new $45.71M New
75 ORIC ORIC PHARMACEUTICALS INC 0.15% — $10 4.00M new $41.00M New
76 EWTX EDGEWISE THERAPEUTICS INC 0.14% — $27 1.48M new $39.53M New
77 DAWNGBX DAY ONE BIOPHARMACEUTICALS I 0.13% — $14 2.56M new $35.64M New
78 DNA GINKGO BIOWORKS HOLDINGS INC 0.11% — $8 3.58M new $29.15M New
79 INBX INHIBRX BIOSCIENCES INC 0.10% — $16 1.79M new $28.00M New
80 TRVI TREVI THERAPEUTICS INC 0.05% — $3 4.40M new $14.70M New
81 PEPG PEPGEN INC 0.05% — $9 1.48M new $12.67M New
82 BNTX BIONTECH SE 0.02% — $119 46K new $5.50M New
83 — RALLYBIO CORP 0.02% — $1 4.19M new $4.91M New

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • US BANCORP DEL 5.60% · $1.54B
  • ADOBE INC 4.95% · $1.36B
  • APPLE INC 4.13% · $1.13B
  • PHILIP MORRIS INTL INC 4.01% · $1.10B
  • VISA INC 3.51% · $964M
  • none reported
  • Filing detail
    Period2024-09-30
    Accepted14 Nov 2024 · 16:00 ET
    Filing lag45 days
    Form13F-HR
    Information rows83
    Quarters on file8
    Portfolio value
    Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026$38.50B Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 202691
    Quarterly history · 8 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q2 2026 2026-06-30 $35.08B 90 6.3% 35 22 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $35.75B 77 5.4% 20 19 15 May 2026 ET 45
    Q4 2025 2025-12-31 $37.68B 76 4.1% 21 23 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $38.50B 78 4.2% 15 20 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $34.59B 83 4.3% 20 28 14 Aug 2025 ET 45
    Q1 2025 2025-03-31 $31.48B 91 4.7% 27 22 15 May 2025 ET 45
    Q4 2024 2024-12-31 $30.90B 86 5.8% 22 19 14 Feb 2025 ET 45
    Q3 2024 2024-09-30 $27.44B 83 5.6% — — 14 Nov 2024 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q3 2024
    +24.2%
    S&P 500 +28.0%
    Hit rate · latest book
    37%
    priced positions with positive return
    Priced coverage
    89%
    of reported stock value
    Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q2 2026 -1.9% -4.1% +2.3% 89% V +18.0%
    Q1 2026 +8.5% +0.9% +7.6% 93% V +32.2%
    Q4 2025 +8.2% +9.6% -1.4% 91% AMD +150.4%
    Q3 2025 +9.3% +11.7% -2.3% 92% AMD +106.1%
    Q2 2025 +12.5% +16.7% -4.2% 92% TSM +58.2%
    Q1 2025 +17.8% +27.8% -10.0% 89% BBIO +130.3%
    Q4 2024 +17.6% +24.1% -6.6% 90% BBIO +122.6%
    Q3 2024 +24.2% +28.0% -3.8% 88% BBIO +222.2%
    Copy-trade simulation
    Hypothetical strategy
    +27.8%
    8 rebalances
    S&P 500 same window
    +28.0%
    excess -0.1%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.